Unternehmen BBI Life Sciences Corporation
Aktien
1035
KYG1089Y1180
1035
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
Xiao Lei Gu
DFI | Director of Finance/CFO | 43 | 11.09.15 |
Jin Wang
PSD | President | 53 | - |
Bin Liu
BRD | Director/Board Member | 41 | 30.10.19 |
Mi Zhou
BRD | Director/Board Member | 41 | - |
Heng Hu
SEC | Corporate Secretary | 44 | - |
Sau Mei Ng
SEC | Corporate Secretary | 47 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Qi Song Wang
CHM | Chairman | 83 | - |
Jian Jun Liu
BRD | Director/Board Member | 56 | 16.01.14 |
Luo Jia Wang
CEO | Chief Executive Officer | 55 | - |
Jin Wang
PSD | President | 53 | - |
Mi Zhou
BRD | Director/Board Member | 41 | - |
Bin Liu
BRD | Director/Board Member | 41 | 30.10.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 560 522 623 | 249 121 411 ( 44,44 %) | 0 | 44,44 % |
Unternehmenskontakt
BBI Life Sciences Corp.
No. 698, Xiangmin Road Songjiang District
201611, Shanghai
+
http://www.bbi-lifesciences.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+21.41% | 42.68 Mrd. | |
-2.55% | 42.4 Mrd. | |
+45.32% | 40.04 Mrd. | |
-6.20% | 28.31 Mrd. | |
+8.01% | 24.94 Mrd. | |
-20.10% | 18.96 Mrd. | |
+30.08% | 12.3 Mrd. | |
-2.48% | 11.95 Mrd. | |
-2.76% | 11.55 Mrd. |